Categories: Health

argenx to Present at Goldman Sachs 46th Annual Global Healthcare Conference

 | Source: argenx SE

June 3, 2025

Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that Karl Gubitz, Chief Financial Officer, will participate in a fireside chat at the Goldman Sachs 46th Annual Global Healthcare Conference on Tuesday, June 10, 2025 at 8:40 AM ET in Miami, FL.

A live webcast of the presentation may be accessed on the Investors section of the argenx website at argenx.com/investors. A replay of the webcast will be available on the argenx website for approximately 30 days following the presentation.

About argenx

argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases. Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx aims to translate immunology breakthroughs into a world-class portfolio of novel antibody-based medicines. argenx developed and is commercializing the first approved neonatal Fc receptor (FcRn) blocker and is evaluating its broad potential in multiple serious autoimmune diseases while advancing several earlier stage experimental medicines within its therapeutic franchises. For more information, visit www.argenx.com and follow us on LinkedInInstagramFacebook, and YouTube.

Contacts

Media:

Ben Petok
bpetok@argenx.com

Investors:

Alexandra Roy
aroy@argenx.com

GlobeNews Wire

Recent Posts

ROCKET DOCTOR AI INC. ANNOUNCES AUTOMATIC CONVERSION OF SPECIAL WARRANTS

Vancouver, British Columbia, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (the “Company”…

1 hour ago

Constellation Software Inc. Announces Conference Call

September 26, 2025 17:03 ET  | Source: Constellation Software Inc. TORONTO, Sept. 26, 2025 (GLOBE…

1 hour ago

Axtria Recognized as Leading AI Service Provider with Minsky Award at Cypher 2025

NEW DELHI, Sept. 26, 2025 /PRNewswire/ -- Axtria Inc., a global leader in AI-first data…

1 hour ago

The Hidden Genetic Threat Putting 1 in 5 at Cardiovascular Disease Risk: Global Experts Call for Action on Elevated Lipoprotein(a)

Cardiovascular disease (CVD) kills nearly 18 million people each year, more than all cancers combined1,2Elevated…

1 hour ago

XPPen Launches Artist Ultra 16: Redefining Professional Pen Displays with Next-Gen Touch Solution and 4K OLED

LOS ANGELES, Sept. 26, 2025 /PRNewswire/ -- XPPen, a global leader in digital art innovation,…

2 hours ago

Yatra Announces Festive Travel Discounts for its Shareholders

~ Exclusive festive discounts on flights and hotels introduced as a token of appreciation for…

2 hours ago